News
Fangzhou has signed a MoU with Novo Nordisk to collaborate on the management of serious chronic diseases, including obesity and diabetes.
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...
Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier ...
A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic Nineties and beach-body-ready Noughties, the judgement is real. It is ...
Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...
Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...
With their lengthening laundry list of health benefits, drugs like Ozempic and Wegovy are showing promise outside of weight ...
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...
From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results